Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
2 Healthcare Stocks to Buy Hand Over Fist in June
07:45am, Wednesday, 12'th Jun 2024
Vertex Pharmaceuticals and Abbott Laboratories are innovative healthcare leaders. Both companies have robust businesses and excellent potential opportunities.
Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
04:22pm, Tuesday, 11'th Jun 2024
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 11:20 AM ET Company Participants David Altshuler - Chief Scientific Officer Char
Vertex Shares Rising on Expanded Therapy Offerings
12:59pm, Tuesday, 11'th Jun 2024
Global biotechnology company Vertex Pharmaceuticals Incorporated (VRTX) is a market-beating outlier stock.
Biotech Hasn't Been This Blazing Hot Since Early 2021 — Here Are The Top 5
02:34pm, Friday, 07'th Jun 2024
The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
02:34pm, Friday, 07'th Jun 2024
The top five biotech stocks today have several commonalities. Among them are strong ratings.
Vertex Pharmaceuticals Incorporated (VRTX) The 44th Annual William Blair Growth Stock Conference
12:56pm, Friday, 07'th Jun 2024
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX ) The 44th Annual William Blair Growth Stock Conference June 4, 2024 5:00 PM ET Company Participants Reshma Kewalramani - Chief Executive Officer Confe
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that data on TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), also known in the European Union a
Why Is Vertex (VRTX) Up 15.8% Since Last Earnings Report?
12:35pm, Wednesday, 05'th Jun 2024
Vertex (VRTX) reported earnings 30 days ago. What's next for the stock?
Vertex: Like A Fine Wine, This Stock Seems To Get Better With Time
05:37pm, Tuesday, 04'th Jun 2024
Biotech companies, like Vertex Pharmaceuticals, benefit from patents, driving consistent growth. Vertex excels in cystic fibrosis treatments and boasts a promising pipeline of new drugs. Vertex's inno
Health Care Stocks Show Relative Strength as S&P 500 Stalls
03:45pm, Tuesday, 04'th Jun 2024
Several stocks are breaking out and trading near all-time highs.
3 No-Brainer Stocks to Buy in June
06:00am, Sunday, 02'nd Jun 2024
AbbVie covers all the bases for investors -- income, value, and growth. AstraZeneca is an inexpensive stock that has solid growth opportunities.
5 Top Stocks to Buy in June
05:47am, Sunday, 02'nd Jun 2024
SoundHound and Adobe offer two distinctly different ways to invest in AI. Vertex Pharmaceuticals continues to deliver for its shareholders.
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
08:00am, Saturday, 01'st Jun 2024
Eli Lilly is in a buy zone, while weight-loss drug rival Novo Nordisk just forged a lower entry.
Vertex: Poised For Long-Term Growth Driven By Multiple Pipeline Catalysts
11:50am, Thursday, 30'th May 2024
Vertex Pharmaceuticals has a strong focus on cystic fibrosis, which is driving revenue growth and pipeline development. The company has outperformed Johnson & Johnson and the S&P 500 in terms of total
Why Vertex Pharmaceuticals (VRTX) is a Top Growth Stock for the Long-Term
10:51am, Thursday, 30'th May 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
